"Artificial Pancreas Could Be Ready in 2017 For Diabetics"
The Icahn School of Medicine at Mount Sinai will be one of eight test sites for a clinical trial of a new artificial pancreas system. While earlier versions primarily served as blood glucose monitors, the newest technology goes a step further, consisting of a pump worn outside the body, a continuous glucose monitor, which measures glucose from fluid under the skin, and a device that runs continuous algorithms to determine how much insulin should be delivered. Learn more.
Diabetes May Accelerate Blood Cancer Growth, Yet Survival Outcomes Differ by Race
Sep 29, 2023 View All Press Releases
Researchers Identify Potential Target for Treatment Among Patients With Type 2 Diabetes
Aug 04, 2022 View All Press Releases
SARS-CoV-2 Infection Likely Not Associated With Increased Risk of New-Onset Diabetes
Feb 22, 2022 View All Press Releases